To reconstitute TB-500 for laboratory research, adding 2.0 mL of bacteriostatic water to a standard 10mg vial yields a target concentration of 5.0 mg/mL, whereas adding 1.0 mL creates a 10.0 mg/mL solution and 5.0 mL creates a 2.0 mg/mL solution. The precise volume of diluent added depends on the specific assay concentration requirements, pipetting tolerances, and target volumetric delivery needed for your in vitro or animal research protocols.
To reconstitute TB-500 for laboratory research, adding 2.0 mL of bacteriostatic water to a standard 10mg vial yields a target concentration of 5.0 mg/mL, whereas adding 1.0 mL creates a 10.0 mg/mL solution and 5.0 mL creates a 2.0 mg/mL solution. The precise volume of diluent added depends on the specific assay concentration requirements, pipetting tolerances, and target volumetric delivery needed for your in vitro or animal research protocols.
Determining the exact diluent volume required for lyophilized peptides is a foundational procedure in quantitative biochemical research. When preparing a TB-500 10mg vial, investigators must balance final concentration against the physical constraints of the vial capacity and pipetting precision. Bacteriostatic water (0.9% benzyl alcohol in sterile water) serves as the primary diluent due to its bacteriostatic properties, preventing microbial growth during multi-use experimental sampling over extended observation periods.
The standard fill volumes for reconstitution typically range between 1.0 mL and 5.0 mL per vial. Adding 1.0 mL produces a highly concentrated stock solution ideal for high-throughput assays or assays requiring minimal working volume. Conversely, adding 3.0 mL or 5.0 mL dilutes the peptide further, facilitating greater volumetric precision when pipetting micro-liter aliquots in benchtop assays. To streamline your bench calculations, you can utilize our automated interactive reconstitution calculator before proceeding with laboratory handling.
When browsing our complete catalog of research peptides, researchers will find that vial dimensions accommodate up to 5.0 mL of liquid without creating positive pressure, provided proper air displacement techniques are employed during diluent addition.
The table below outlines the resultant stock concentrations for common TB-500 vial masses (2mg, 5mg, and 10mg) when combined with standard bacteriostatic water diluent volumes of 1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL. All calculations reflect mass-to-volume ratios ($C = m / V$) measured at standard laboratory temperatures (20°C to 22°C).
10mg TB-500 Vial Mass: - Reconstitution with 1.0 mL BAC Water = 10.0 mg/mL (100 mcg per 10 µL) - Reconstitution with 2.0 mL BAC Water = 5.0 mg/mL (50 mcg per 10 µL) - Reconstitution with 3.0 mL BAC Water = 3.33 mg/mL (33.3 mcg per 10 µL) - Reconstitution with 5.0 mL BAC Water = 2.0 mg/mL (20 mcg per 10 µL)
5mg TB-500 Vial Mass: - Reconstitution with 1.0 mL BAC Water = 5.0 mg/mL (50 mcg per 10 µL) - Reconstitution with 2.0 mL BAC Water = 2.5 mg/mL (25 mcg per 10 µL) - Reconstitution with 3.0 mL BAC Water = 1.67 mg/mL (16.7 mcg per 10 µL) - Reconstitution with 5.0 mL BAC Water = 1.0 mg/mL (10 mcg per 10 µL)
2mg TB-500 Vial Mass: - Reconstitution with 1.0 mL BAC Water = 2.0 mg/mL (20 mcg per 10 µL) - Reconstitution with 2.0 mL BAC Water = 1.0 mg/mL (10 mcg per 10 µL) - Reconstitution with 3.0 mL BAC Water = 0.67 mg/mL (6.7 mcg per 10 µL) - Reconstitution with 5.0 mL BAC Water = 0.40 mg/mL (4.0 mcg per 10 µL)
Choosing the optimal row and column from this grid depends on your laboratory equipment. For example, if micropipettes in your facility demonstrate highest accuracy between 10 µL and 50 µL, setting a 10mg vial to 5.0 mg/mL (2.0 mL diluent) offers an optimal balance between volumetric delivery and conservation of stock solution.
Calculating concentration requires applying basic mass-by-volume equations. The primary equation governing reconstituted peptide stock is defined as Concentration ($C$) = Mass ($m$) ÷ Volume ($V$). When mass is expressed in milligrams (mg) and volume in milliliters (mL), the resulting unit is mg/mL, which directly translates to micrograms per microliter (µg/µL).
For example, consider a 10mg vial of TB-500 reconstituted with 2.0 mL of bacteriostatic water diluent. Dividing 10 mg by 2.0 mL yields 5.0 mg/mL. Because 1 mg equals 1,000 µg and 1 mL equals 1,000 µL, a 5.0 mg/mL concentration is equivalent to 5.0 µg/µL (or 50 µg per 10 µL pipetted volume). If an in vitro assay requires a working mass of 250 µg per culture well, the required pipette volume is calculated as Volume = Mass ÷ Concentration = 250 µg ÷ 5.0 µg/µL = 50 µL.
Understanding this simple conversion eliminates dose errors during preclinical micro-plate assays. To double-check all lot purity calculations before working with reconstituted media, investigators can inspect our lot-specific COA database for verified peptide content weights.
Reconstituting lyophilized peptides under sterile conditions is vital to maintaining molecular integrity and preventing bacterial degradation. Begin by sanitizing a laminar flow hood or clean bench workspace with 70% isopropanol. Remove the flip-off cap from the TB-500 vial and wipe the rubber stopper with an alcohol swab, allowing it to air-dry completely.
Using a sterile syringe fitted with an appropriate gauge needle (e.g., 21G to 25G), draw the precise volume of bacteriostatic water calculated for your working stock (e.g., 2.0 mL). Insert the needle through the center of the rubber septum at a 45-degree angle to prevent coring. Allow the vacuum inside the vial to pull the diluent gently inward. Direct the liquid stream against the glass wall of the vial rather than shooting it directly into the lyophilized cake to protect delicate peptide bonds.
Once the diluent is added, gently swirl the vial in a circular motion on the benchtop until the lyophilized cake is fully dissolved. Do not shake or vortex the vial vigorously, as shear forces can induce peptide aggregation or denaturation. Inspect the solution under bright light; it should appear clear, colorless, and free of undissolved particulate matter.
Repeated freeze-thaw cycles significantly accelerate the degradation of synthetic peptides in aqueous solution. To maximize stability, researchers should aliquot freshly reconstituted TB-500 stock into single-use microcentrifuge tubes immediately following full solubilization.
Working aliquots should be calculated based on daily or weekly assay consumption volumes. For short-term experimental series (up to 28 days), reconstituted TB-500 stored in bacteriostatic water can remain at 4°C. The 0.9% benzyl alcohol preservative acts as an antimicrobial agent, preventing bacterial cell division.
For long-term storage exceeding four weeks, sub-aliquoted tubes should be stored at -20°C or -80°C in non-frost-free freezers. Avoid frost-free units, as their internal heating cycles induce temperature fluctuations that break down peptide structures over time. Thaw aliquots slowly on ice immediately prior to introduction into cell culture media or analytical instrumentation.
TB-500 is a synthetic peptide fraction corresponding to the active region of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid actin-sequestering protein found in high concentrations in most tissues. As a primary regeneration peptide, TB-500 has been widely studied in structural biology and cell culture models for its capacity to regulate globular actin (G-actin) polymerization into filamentous actin (F-actin).
Preclinical studies suggest that TB-500 plays a crucial role in promoting cell migration, blood-vessel formation (angiogenesis), and tissue flexibility during soft-tissue and muscle-fiber recovery models. In vitro data indicate that by sequestering G-actin monomers, TB-500 facilitates rapid cellular motility across extracellular matrices, allowing endothelial cells and fibroblasts to migrate toward sites of tissue injury.
Furthermore, animal models investigating soft-tissue remodeling report enhanced extracellular matrix alignment and microvascular density following exposure to synthetic Thymosin Beta-4 fragments. For deeper technical literature on tissue repair cascades, researchers can consult our comprehensive peptide research library.
In soft-tissue and cellular migration assays, TB-500 is frequently evaluated alongside other prominent research compounds. Understanding the mechanistic differences between these compounds allows researchers to select appropriate co-factors or standalone controls for their models.
For instance, BPC-157 is a pentadecapeptide investigated for its focal adhesion kinase upregulation and nitric oxide pathways, operating via distinct intracellular cascades compared to TB-500's actin-binding mechanisms. Similarly, copper-complexed peptides like GHK-Cu are utilized in wound-healing models to study collagen synthesis and gene transcription remodeling, while CJC-1295 is deployed in endocrine signaling models.
When running multi-variate tissue repair experiments, researchers often source high-purity lots through bulk laboratory accounts to ensure consistent intra-assay baseline parameters across large sample sets.
Assay reproducibility depends on the physical purity and raw material quality of the target peptide. Low-grade research compounds containing synthesis byproducts, truncated sequences, or residual TFA (trifluoroacetic acid) can yield inconsistent cellular responses and invalidate quantitative findings.
At PX1 Research, every lot of TB-500 undergoes rigorous third-party analytical testing in an ISO 17025 accredited laboratory. Purity is validated via High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to ensure a minimum purity threshold of 99%. Additionally, all batches are tested for bacterial endotoxins (LAL testing) to ensure suitability for sensitive cell culture and animal tissue models.
Detailed certificates of analysis displaying raw chromotograms and mass spectra are publicly published for every production lot, reinforcing our commitment to transparent, science-forward laboratory supply.
How much bacteriostatic water should be added to a 10mg TB-500 vial?
Adding 2.0 mL of bacteriostatic water to a 10mg TB-500 vial creates a standard target concentration of 5.0 mg/mL. Adding 1.0 mL yields a 10.0 mg/mL solution, while 5.0 mL yields a 2.0 mg/mL solution.
What is the purpose of bacteriostatic water versus sterile water in peptide reconstitution?
Bacteriostatic water contains 0.9% benzyl alcohol, which acts as a preservative to inhibit bacterial growth during repeated multi-use sampling over 28 days. Sterile water lacks preservatives and must be used immediately upon opening.
How long is reconstituted TB-500 stable at 4°C?
When reconstituted with bacteriostatic water under sterile conditions, working stock solutions of TB-500 remain stable at 4°C for up to 28 days.
Can reconstituted TB-500 be frozen for extended storage?
Yes, reconstituted TB-500 can be sub-aliquoted into single-use sterile microcentrifuge tubes and stored at -20°C or -80°C for long-term preservation, provided freeze-thaw cycles are strictly avoided.
What should I do if the TB-500 lyophilized cake does not dissolve immediately?
Gently swirl the vial between your palms or on a flat benchtop. Never shake or vortex the vial, as mechanical agitation can denature the peptide structure. Complete dissolution usually occurs within 1–3 minutes.
Where can I verify the purity of my PX1 Research TB-500 lot?
Lot-specific third-party HPLC and MS analytical reports are accessible directly through our online COA database using the batch code printed on your vial.
What primary research areas involve TB-500?
TB-500 is investigated in preclinical research for promoting cell migration, blood-vessel formation (angiogenesis), and flexibility during soft-tissue and muscle-fiber recovery.
Is TB-500 approved for human administration?
No. All products provided by PX1 Research are strictly for laboratory research use only and are not intended for human, clinical, or veterinary applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.